AXL targeting overcomes human lung cancer cell resistance to NK and CTL-mediated cytotoxicity

ABSTRACT: To investigate the effect of AXL inhibition on gene expression in carcinoma cell clones derived from NSCLC IGR-Heu cells, we profiled gene expression in cells treated with the AXL inhibitor bemcentinib (1 µmol/L) or with vehicle (dmso) for 72 hours

ORGANISM(S): Homo sapiens

SUBMITTER: Stephane Terry 

PROVIDER: E-MTAB-8294 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress